TriSalus Life Sciences (TLSIW) Gross Profit (2022 - 2026)

TriSalus Life Sciences (TLSIW) has 5 years of Gross Profit data on file, last reported at $7.7 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit changed 0.04% year-over-year to $7.7 million; the trailing twelve-month figure through Mar 2026 stood at $38.2 million (up 38.78% YoY), and the FY2025 full-year result was $38.2 million, up 50.77% from the prior year.
• Gross Profit for Q1 2026 stood at $7.7 million, down from $11.4 million in the prior quarter.
• Across five years, Gross Profit topped out at $11.4 million in Q4 2025 and bottomed at $2.3 million in Q1 2023.
• The 5-year median for Gross Profit is $6.3 million (2024), against an average of $6.2 million.
• The widest annual swing landed in 2024, when Gross Profit soared 136.26%; it then decreased 0.04% in 2026.
• A 5-year view of Gross Profit shows it stood at $2.4 million in 2022, then surged by 113.24% to $5.1 million in 2023, then surged by 37.09% to $7.0 million in 2024, then jumped by 62.43% to $11.4 million in 2025, then tumbled by 32.98% to $7.7 million in 2026.
• The last three Gross Profit figures came in at $7.7 million (Q1 2026), $11.4 million (Q4 2025), and $9.7 million (Q3 2025), per Business Quant data.

Peer Comparison